Omega-6 and Omega-3 Fatty Acid Levels Inversely Tied to Cancer Incidence
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer, according to a study published online Oct. 17 in the International Journal of Cancer.
Yuchen Zhang, from the University of Georgia in Athens, and colleagues investigated the associations of plasma omega-3 and omega-6 PUFAs with the incidence of cancer (overall and 19 site-specific cancers). The analysis included 253,138 eligible U.K. Biobank participants followed for 12.9 years.
The researchers found that both omega-6 and omega-3 as percentages of total fatty acids were inversely associated with overall cancer incidence (hazard ratios [95 percent confidence intervals] per standard deviation [SD], 0.98 [0.96 to 0.99] and 0.99 [0.97 to 1.00], respectively). Fourteen of the 19 site-specific cancers available were associated with omega-6 percentage and five were associated with omega-3 percentage, all indicating inverse associations, with the exception that prostate cancer was positively associated with omega-3 percentage (hazard ratio per SD, 1.03; 95 percent confidence interval, 1.01 to 1.05).
"Higher omega-3 and omega-6 levels were associated with lower rates of cancer," Zhang said in a statement. "These findings suggest that the average person should focus on getting more of these fatty acids in their diets."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2024
Read this next
Considerable Disparities in Life Expectancy Exist Within U.S. Population
FRIDAY, Nov. 22, 2024 -- There are considerable differences in life expectancy between different groups within the U.S. population, according to a study published online Nov. 21...
COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
THURSDAY, Nov. 21, 2024 -- The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have...
AI Model FastGlioma Can Detect Glioma Infiltration During Surgery
THURSDAY, Nov. 21, 2024 -- The artificial intelligence (AI) model FastGlioma can detect glioma infiltration during surgery, according to a study published online Nov. 13 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.